Detalhe da pesquisa
1.
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
Europace
; 22(1): 47-57, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651951
2.
Incorporating patient generated health data into pharmacoepidemiological research.
Pharmacoepidemiol Drug Saf
; 29(12): 1540-1549, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146896
3.
Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Respiration
; 99(2): 108-118, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31982886
4.
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Am Heart J
; 218: 123-127, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806087
5.
Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Diabetes Obes Metab
; 21(8): 1824-1836, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30941884
6.
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
Am Heart J
; 198: 55-63, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653649
7.
Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study.
Diabetes Obes Metab
; 20(7): 1642-1651, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498473
8.
Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Diabetes Obes Metab
; 20(4): 974-984, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29206336
9.
Real world management of pregestational diabetes not achieving glycemic control for many patients in the UK.
Pharmacoepidemiol Drug Saf
; 27(8): 940-948, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29740916
10.
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Europace
; 18(9): 1308-18, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27335063
11.
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.
Diabetologia
; 57(11): 2237-50, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25212258
12.
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Am Heart J
; 167(3): 329-34, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576516
13.
Prospective cohort studies of newly marketed medications: using covariate data to inform the design of large-scale studies.
Epidemiology
; 25(1): 126-33, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240651
14.
Metrics for covariate balance in cohort studies of causal effects.
Stat Med
; 33(10): 1685-99, 2014 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24323618
15.
Procalcitonin and valuable clinical symptoms in the early detection of neonatal late-onset bacterial infection.
Acta Paediatr
; 101(1): 19-25, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21824193
16.
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
Clin Res Cardiol
; 111(5): 548-559, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294623
17.
Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
PLoS One
; 17(10): e0274237, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201473
18.
Choosing Among Common Data Models for Real-World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products.
Clin Pharmacol Ther
; 107(4): 827-833, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330042
19.
Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation.
Clin Pharmacol Ther
; 107(6): 1405-1419, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31869437
20.
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
J Clin Med
; 9(6)2020 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32586056